Form 8-K - Current report:
SEC Accession No. 0001558370-24-015780
Filing Date
2024-11-15
Accepted
2024-11-15 08:00:16
Documents
13
Period of Report
2024-11-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K mrns-20241114x8k.htm   iXBRL 8-K 40405
  Complete submission text file 0001558370-24-015780.txt   164007

Data Files

Seq Description Document Type Size
2 EX-101.SCH mrns-20241114.xsd EX-101.SCH 3255
3 EX-101.LAB mrns-20241114_lab.xml EX-101.LAB 16593
4 EX-101.PRE mrns-20241114_pre.xml EX-101.PRE 10715
15 EXTRACTED XBRL INSTANCE DOCUMENT mrns-20241114x8k_htm.xml XML 5113
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Filer) CIK: 0001267813 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36576 | Film No.: 241465889
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)